Phenytoin neurotoxicity
Rodríguez Gaspar, M.A.; Martínez Riera, A.; González Reimers, E.; Santolaria Fernández, F.
Anales de Medicina Interna 17(11): 619-620
2000
ISSN/ISBN: 0212-7199 PMID: 11322044 Document Number: 512838
Document emailed within 1 workday
Related Documents
Jefferys, R.J. 2005: Lower phenytoin serum levels in persons switched from brand to generic phenytoin Neurology 65(4): 657-8; Author Reply 657-8Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76
Jortner, B.S.; Cho, E.S. 1981: Neurotoxicity of quelamycin in the rat Neurotoxicology 2(4): 789-792
Hutchinson, B.R. 2003: Lignocaine neurotoxicity New Zealand Medical Journal 116(1178): U525
Winneke, G. 1981: The neurotoxicity of dichloromethane Neurobehavioral Toxicology and Teratology 3(4): 391-395
1990: Cisplatin neurotoxicity New England Journal of Medicine 323(1): 64-65
Blundell, J.E. 1992: Dexfenfluramine and neurotoxicity Lancet 339(8789): 359-60; Author Reply 360-1
Ginn, H.E.; Teschan, P.E.; Walker, P.J.; Bourne, J.R.; Fristoe, M.; Ward, J.W.; McLain, L.W.; Johnston, H.B.; Hamel, B. 1975: Neurotoxicity in uremia Kidney International. Supplement 1975(3): 357-360
Kopp, K.; Hansen, S.W. 1991: Neurotoxicity in chemotherapy Sygeplejersken 91(49): 4-8
Murray, J.R. 1978: Bismuth neurotoxicity Medical Journal of Australia 1(5): 279-280
Aggarwal, P. 1994: INH-induced neurotoxicity Journal of the Association of Physicians of India 42(5): 429
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Tweddle, D.A.; Windebank, K.P.; Hewson, Q.C.; Yule, S.M. 1999: Cyclosporin neurotoxicity after chemotherapy Bmj 318(7191): 1113
Forloni, G. 1993: Beta-Amyloid neurotoxicity Functional Neurology 8(3): 211-225
Glinka, Y.; Gassen, M.; Youdim, M.B. 1997: Mechanism of 6-hydroxydopamine neurotoxicity Journal of Neural Transmission. Supplementum 50: 55-66
Caldron, P.H.; Wilbourn, A.J. 1988: Gold neurotoxicity and myokymia Journal of Rheumatology 15(3): 528-529
Wallace, I.W. 1970: Neurotoxicity associated with a reaction to sulphasalazine Practitioner 204(224): 850-851
Witkin, J.M.; Alvarado-Garcia, R.; Lee, M.A.; Witkin, K.M. 1987: Nonmuscarinic neurotoxicity of oxotremorine Journal of Pharmacology and Experimental Therapeutics 241(1): 34-41